| 呼吸器・乳腺外科学 | |||||||
| Thoracic and Breast Surgery | |||||||
| 整理番号 | 論文の種類 | 著者名 | 論文タイトル | 誌名、書名等 | 巻号ページ | 年 | doi |
| 2346001 | 原著 | Okamoto T, Miyawaki M, Toyokawa G, Karashima T, Abe M, Takumi Y, Hashimoto T, Osoegawa A, Tagawa T, Takeuchi H, Shimokawa M, Sugio K | Clinical significance of part-solid lung cancer in the eighth edition TNM staging system. | Interact Cardiovasc Thorac Surg. | 34(2): 219-226 | 2022 | 10.1093/icvts/ivab255. |
| 2346002 | 原著 | Takahashi T, Sakai K, Kenmotsu H, Yoh K, Daga H, Ohira T, Ueno T, Aoki T, Hayashi H, Yamazaki K, Hosomi Y, Chen-Yoshikawa TF, Okumura N, Takiguchi Y, Sekine A, Haruki T, Yamamoto H, Sato Y, Akamatsu H, Seto T, Sugio K, Nishio M, Inokawa H, Yamamoto N, Nishio K, Tsuboi M. | Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy. | Cancer Sci. | 113(1): 287-296 | 2022 | 10.1111/cas.15171. |
| 2346003 | 原著 | Tada H, Mitsudomi T, Misumi T, Sugio K, Tsuboi M, Okamoto I, Iwamoto Y, Sakakura N, Sugawara S, Atagi S, Takahashi T, Hayashi H, Okada M, Inokawa H, Yoshioka H, Takahashi K, Higashiyama M, Yoshino I, Nakagawa K | Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT). | J Clin Oncol. | 40(3): 231-241 | 2022 | 10.1200/JCO.21.01729. |
| 2346004 | 原著 | Yano T, Hamatake M, Tokunaga S, Okamoto T, Yamazaki K, Miura T, Nagayasu T, Sato M, Fukuyama S, Sugio K | A prospective observational study of postoperative adjuvant chemotherapy for non-small cell lung cancer in elderly patients (≥ 75 years). | Int J Clin Oncol. | 27(5): 882-888 | 2022 | 10.1007/s10147-022-02143-7. |
| 2346005 | その他 | 杉尾 賢二 | 大分大学医学部呼吸器・乳腺外科学講座「肺癌，乳癌診療 -未来に繋ぐ−」 | 大分県医師会会報 | (816): 24-26 | 2022 | 大学便り 医大ケ丘通信第79号 令和4年9月10日発行 |
| 2346006 | 症例報告 | Nagaoka Y, Kosaku K, Yoshikawa H, Abe M, Miyawaki M, Daa T, Hiramatsu K, Sugio K, Kadota J | Aspergillus Nodule in a Patient With Autoimmune Pulmonary Alveolar Proteinosis. | Cureus | 14(9): 29095 | 2022 | 10.7759/cureus.29095 |
| 2346007 | 原著 | Fukuda M, Yamaguchi M, Yamazaki T, Funaki S, Mukae H, Fukuoka J, Nabeshima K, Tateyama H, Ashizawa K, Tomiyama N, Hara M, Seto M, Okumura M, Sugio K | Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study. | Thorac Cancer | 13(17): 2499-2506 | 2022 | 10.1111/1759-7714.14586. Epub 2022 Jul 22. |
| 2346008 | 症例報告 | Oyake M, Suenobu S, Miyawaki M, Ohchi Y, Ihara K | Airway Emergencies Due to Anterior Mediastinal T-Lymphoblastic Lymphoma Managed With Planned Extracorporeal Membrane Oxygenation and Endotracheal Stent: A Case Report and Literature Review. | Cureus | 4(2): 21799-21799 | 2022 | 10.7759/cureus.21799. eCollection 2022 Feb. |
| 2346009 | 著書 | 杉尾 賢二 | V. 治療 その他 「新型コロナウイルス感染症(COVID-19)パンデミックと肺癌診療 | 日本臨床 第80巻 増刊号8(通常第1225号)「最新臨床肺癌学−診断・治療の最新動向−」 | 80(0): 671-676 | 2022 | 株式会社日本臨床社 2022年12月31日 初版第1刷発行 |
| 2346010 | 症例報告 | 清田 貴茂, 高田 彰子, 松本 陽, 大塚 誠, 糸谷 真保, 足立 徹, 大木 玲子, 木許 賢一, 小副川 敦, 杉尾 賢二, 西川 和男, 西田 陽登, 駄阿 勉, 浅山 良樹 | 脈絡膜転移に対して緩和照射を施行した3例 | Palliative Care Research | 17(1): 17-22 | 2022 | https://doi.org/10.2512/jspm.17.19 |
| 2346011 | Proceedings | Osoegawa A、Takumi Y、Karashima T、Abe M、Hashimoto T、Miyawaki M、Sugio K | First Line Osimertinib in Lung Cancer Patients with
Postoperative Recurrence. |
IASLC 2022 World Conference on Lung Cancer | 2022 | ||
| 2346012 | Proceedings | Hashimoto T、Karashima T、Abe M、Takumi Y、Miyawaki M、Inagaki T、Nishikawa K、Osoegawa A、Sugio K | Analysis of Outcome of Cancer Immunotherapy for Recurrent Cancer after Surgery for Non-Small Cell Lung Cancer. | IASLC 2022 Asia Conference on Lung Cancer | 2022 | ||
| 2346013 | Proceedings | Takumi Y、Arai S、Suzuki C、Fukuda K、Nisiyama A、Takeuchi S、Sato H、Matsumoto K、Osoegawa A、Sugio K、Yano S | MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements. | 12TH AACR-JCA JOINT CONFERENCE | 2022 | ||
| 2346014 | Proceedings | Nakamura A, Saito R, Ko R, Azuma K, Morita R, Maemond M, Oizumi S, Takahashi K, Kagamu H, Isobe T, Seike M, Kikuchi T, Okamoto I, Morita S, Asahina H, Tanaka K, Sugio K, Kobayashi K | A phase II study of Osimertinib in combination with platinum plus pemetrexed in patients with EGFR-mutated, advancced non-small cell lung cancer: The OPAL study (NEJ032C/LOGIK1801) | ASCO 2022 Annual Meeting | 2022 | ||
| 2346015 | Proceedings | Yamaguchi H, Wakuda K, Fukuda M, Kenmotsu H, Ito K, Kawano Y-T, Tanaka K, Harada T, Nakatani Y, Miura S, Yokoyama T, Nakamura T, Izumi M, Nakamura A, Ikeda S, Takayama K, Yoshimura K, Nakagawa K, Yamamoto N, Sugio K. | Osimertinib for RT-naive CNS Matastasis of EGFR mutation positive NSCLC: phase II OCEAN Study(LOGIK1603/WJOG9116L), Oart of the First-line cohort. | 2022 | |||